Dr Uma Sharma

Dr. Uma Sharma is a visionary drug developer recognized for her strengths in business as a national finalist and winner of the Entrepreneur of the Year award for Michigan (2020). Dr. Sharma has successfully led several global applications, including rare disease and orphan drug approvals. In collaboration with her data-focused teams, she has pioneered several new data and submission strategies, including using RWE in new drug applications.

Uma brings vision and leadership to the organization and supports community efforts as a member of the MichBio board. Her strengths, in particular, are around defining the corporate culture and team efficiencies and establishing a customer- and patient-focused global organization. Under Uma’s leadership, MMS has received multiple awards, including Best Places to Work.

Dr. Sharma earned her doctorate in pharmacology from Wayne State University and the University of Michigan.

Every colleague across the globe carries our core values into their day-to-day tasks. At the grassroots level internally, is SOUL (Sense of Urgency and Leadership) – one of our corporate values that epitomizes responsibility and hard work. SOUL continues to be appreciated by clients on every project that we support, and this is a key differentiator from other CROs.
Uma Sharma

Suggested For You

perspectives

March 25th, 2026

REMS and Labeling Are Strategic Design Decisions, Not Late-Stage Add-Ons

perspectives

March 12th, 2026

AI in Pharma: Autopilot Is Not the Same as Removing the Pilot 

webinar

April 30th, 2026

Inside FDA REMS Decision-Making: A Fireside Chat for Sponsors

perspectives

March 3rd, 2026

Modeling and Simulation in Clinical Trials: A Practical Approach to De-Risking Study Design

perspectives

February 25th, 2026

Integrating AI and Automation Into Clinical Trial Operations With Discipline and Transparency

perspectives

February 10th, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

February 5th, 2026

MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions 

perspectives

February 3rd, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

January 29th, 2026

Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

ebook

January 27th, 2026

A Practical Guide to Expedited Regulatory Pathways

perspectives

January 27th, 2026

What Regulators Want to See in Surrogate Endpoints Today 

perspectives

January 20th, 2026

Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration